Developing Next-Generation in Vivo Cell and Gene Therapies
Oct 17, 2022
01:07:03
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
David Johnson, founder and CEO of GigaMune, sits down with Neil to discuss his company's efforts to develop in vivo cell and gene therapies to treat cancer and autoimmune conditions.
